/

ECOR

electroCore, Inc.Closed

8.39−0.89 −9.59%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delay

Open

9.19

Prev close

9.28

Day range

8.229.39

52-week range

4.4112.70

Volume

184.74K2.28×

Mkt cap

75.64M

P/E ttm

—

Fwd P/E

-15.25

EPS ttm

-1.65

Div yield

0.00%

Earnings

Aug 6, 2026

From 52w high

−33.94%

Price Chart

Yahoo Finance · delayed

ECOROct 13, 2026O 9.12H 9.39L 8.15C 8.39−0.89 (−9.59%)Vol 184.70K

SMA 509.81
SMA 2007.57

1Y change +67.80% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

ECOR electroCore, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −15.42%
1 month: −12.79%
3 months: +36.42%
6 months: +28.09%
Year to date: +87.07%
1 year: +67.80%

Valuation & ownership

Market cap: 75.64M
Enterprise value: 75.16M
P/E (ttm): —
Forward P/E: -15.25
PEG ratio: —
Price / book: —
Price / sales (ttm): 2.05
EV / EBITDA: -5.50
EPS (ttm): -1.65
EPS (forward): -0.5500
Beta (5y monthly): 1.05
Dividend yield: 0.00%
Payout ratio: —
Shares outstanding: 9.02M
Float: 5.98M
Short % of float: 3.64%
Short ratio (days): 3.69
Held by insiders: 34.19%
Held by institutions: 11.93%
Avg volume (3m): 81.01K
50-day average: 9.77
200-day average: 7.56
52-week change: +67.80%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 30.5
vs 50-day SMA: −14.50%
vs 200-day SMA: +10.78%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▼ below
ATR (14) % of price: 8.74%
Realised vol (20d, ann.): 63.3%
From 52-week high: −33.94%
From 52-week low: +90.25%

ANR

Analyst Consensus

5 analysts

Consensus

—

Mean target

19.17

+128.49% implied

Low 12.00Median 19.85High 26.00

Recommendation trend

Now5 / 0 / 0
1m ago5 / 0 / 0

Buy / hold / sell counts

DES

About electroCore, Inc.

Yahoo Finance profile

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Sector: Healthcare
Industry: Medical Devices
Employees: 83
Headquarters: Rockaway, NJ, United States
Website: electrocore.com
Officers: Dr. Thomas J. Errico M.D. Founder & Independent Chairman
Mr. Joshua S. Lev CFO, Interim CEO, President & Director
Mr. Michael Fox COO, Interim CEO, Interim President & Director

SEAS

Seasonality · ECOR

2018–2026 · monthly returns

Strongest month Jan +19.21%Weakest month May −17.24%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	48.5	13.8	-20.4	8.0	49.9	-11.5	-29.6	56.0	14.0	-22.5			+87.1%
2025	3.1	-9.0	-56.0	9.9	-32.0	5.6	31.1	-23.3	-6.8	1.8	0.2	-11.2	−72.3%
2024	27.2	-8.5	-11.0	1.1	3.1	0.0	-5.6	-0.4	19.3	57.9	7.0	32.9	+172.3%
2023	36.2	-36.2	64.2	11.6	-20.7	0.6	-8.2	24.4	8.4	0.8	-8.2	5.9	+54.4%
2022	16.6	-13.1	-1.0	-27.7	5.9	13.8	12.9	-8.0	-23.4	-36.0	27.3	-22.4	−55.9%
2021	65.4	-15.9	-5.1	-17.5	-1.2	-29.2	-12.6	-1.0	9.7	-16.8	-25.4	-16.8	−62.6%
2020	-20.8	-42.1	30.1	1.1	-3.1	-11.6	171.3	-20.6	-2.3	-12.7	-0.7	4.0	−1.9%
2019	6.7	30.8	-19.9	-10.7	-72.6	17.0	-29.5	35.5	14.7	-27.9	-4.4	5.3	−74.6%
2018							-18.2	20.7	-14.1	-28.4	-33.6	-6.0	−62.1%

INSD

Insider Activity · ECOR

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

296.2K shares

Sells, 6 months

125.7K shares

Net shares

+170.4K

Net change in insider shares

+5.90%

Date	Insider	Transaction	Shares	Value
Sep 13, 2026	Errico Thomas J.Director	Purchase at price 9.82 per share.	5K	$49.08K
Sep 10, 2026	Fox MichaelChief Executive Officer	Stock Award(Grant) at price 9.80 per share.	5K	$49.00K
Sep 8, 2026	Errico Thomas J.Director	Stock Award(Grant) at price 0.00 per share.	15.6K	—
Sep 8, 2026	Goldstein Julie AnnDirector	Stock Award(Grant) at price 0.00 per share.	11.1K	—
Sep 8, 2026	Wilber PatriciaDirector	Stock Award(Grant) at price 0.00 per share.	11.1K	—
Sep 8, 2026	Theofilos JamesDirector	Stock Award(Grant) at price 0.00 per share.	11.1K	—
Sep 8, 2026	Bonfiglioli ElenaDirector	Stock Award(Grant) at price 0.00 per share.	11.1K	—
Sep 8, 2026	Gandolfo John PDirector	Stock Award(Grant) at price 0.00 per share.	11.1K	—
Sep 7, 2026	Lev Joshua S.Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	55K	—
Sep 7, 2026	Fox MichaelChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	55K	—
Aug 24, 2026	Lev Joshua S.President	Sale at price 9.36 - 10.22 per share.	20K	$200.12K
Aug 24, 2026	Lev Joshua S.President	Conversion of Exercise of derivative security at price 4.50 per share.	20K	$90.00K
Aug 12, 2026	Errico Thomas J.Director	Purchase at price 9.85 per share.	5K	$49.27K
May 27, 2026	Lev Joshua S.President	Sale at price 9.00 per share.	6.7K	$60.00K
May 21, 2026	Lev Joshua S.President	Sale at price 6.50 per share.	3K	$19.50K
May 20, 2026	Errico Thomas J.Director	Purchase at price 5.98 - 5.99 per share.	10K	$59.90K
Apr 22, 2026	Goldberger Daniel SFormer	Sale at price 6.80 per share.	80K	$544.00K
Apr 12, 2026	Fox MichaelChief Operating Officer	Stock Award(Grant) at price 0.00 per share.	70K	—
Apr 9, 2026	Goldberger Daniel SFormer	Sale at price 6.02 per share.	16.1K	$96.75K
Mar 31, 2026	Lev Joshua S.Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	45K	—

13F

Investors Holding ECOR

latest 13F filings of 29 followed managers

Investors holding ECOR
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$171.9K	0.00%	19.90K	−55%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

ECOR

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

ECOR

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About electroCore, Inc.

Seasonality · ECOR

Insider Activity · ECOR

Congress Trades · ECOR

Investors Holding ECOR

Investors Holding ECOR

Congress Trades · ECOR

Insider Activity · ECOR

Seasonality · ECOR

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About electroCore, Inc.

Financial Snapshot

Earnings & Dividends

News